Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Camzyos
Pharma
Cytokinetics scores with Myqorzo in key cardiomyopathy trial
Cytokinetics has aced a phase 3 trial of Myqorzo in non-obstructive hypertrophic cardiomyopathy. It is the first successful study in the indication.
Kevin Dunleavy
May 5, 2026 8:00am
BMS maintains Camzyos confidence amid Cytokinetics competition
Apr 30, 2026 2:20pm
FDA expands label for BMS' Sotyktu to treat psoriatic arthritis
Mar 9, 2026 11:16am
Cytokinetics scores its first FDA nod with Myqorzo approval
Dec 22, 2025 12:05pm
Fierce Biotech
Cytokinetics doesn't want Big Pharma help to overtake Camzyos
Nov 18, 2025 1:30pm
BMS' Camzyos falls short in bid to widen eligible patient pool
Apr 15, 2025 11:42am
